Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma

Sho Koyasu, Yuji Nakamoto, Masahiro Kikuchi, Koya Nakatani and Kaori Togashi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 511;
Sho Koyasu
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Nakamoto
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Kikuchi
2Department of Head and Neck Surgery, Kobe City Medical Center General Hospital, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koya Nakatani
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaori Togashi
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

511

Objectives The purpose of this study was to determine whether pretreatment quantitative and visual parameters seen on PET/CT using 18F-FDG add prognostic information for clinical staging in patients with head and neck squamous cell carcinoma (HNSCC).

Methods We enrolled 108 patients with histologically proven oral, oropharyngeal, hypopharyngeal, and laryngeal SCCs who underwent FDG-PET/CT before treatment. PET/CT parameters—maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and uptake pattern—were recorded. We classified the uptake patterns into two groups: sphere-shaped or ring-shaped. The prognostic value of these parameters was evaluated using univariate Cox regression analysis. Multivariate analysis was then applied to examine the effect of these PET/CT parameters adjusted for other covariates.

Results In univariate analysis, all of the FDG PET/CT parameters—SUVmax (> 10) of the primary tumor, MTV (> 20 cm3), TLG (> 70), and uptake pattern (ring-shaped)—were significantly associated with negative effects on disease-specific survival (DSS) and disease-free survival (DFS). In multivariate analysis, the MTV and uptake pattern remained associated with DSS after correcting for the AJCC stage and definitive therapy (P = 0.023 and < 0.001, respectively). SUVmax and TLG were not significantly associated with DSS (P = 0.055 and 0.050, respectively). Another DSS model that included MTV as a continuous variable, uptake pattern, and AJCC stage showed that MTV was not significantly associated with DSS (P = 0.332), but the uptake pattern remained significant (P < 0.001).

Conclusions Our data indicate that pretreatment quantitative and qualitative PET/CT parameters had prognostic value. In particular, a qualitative factor, "uptake pattern," provided important prognostic information about our patients.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma
Sho Koyasu, Yuji Nakamoto, Masahiro Kikuchi, Koya Nakatani, Kaori Togashi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 511;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma
Sho Koyasu, Yuji Nakamoto, Masahiro Kikuchi, Koya Nakatani, Kaori Togashi
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 511;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Time of Flight compared to standard iterative acquisition and reconstruction for assessment of pulmonary nodules.
  • Is childhood obesity linked to lymphoma?
  • Imaging characteristics of 18F-FDG PET/CT in patients with newly diagnosed angio-immunoblastic T cell lymphoma
Show more Oncology: Clinical Diagnosis

Head & Neck II

  • The value of post-therapy F-18 FDG PET/CT surveillance scans in the detection of recurrent nasopharyngeal carcinoma
  • Does PET/CT improve patient management after curative-intent radiotherapy (RT) for head & neck squamous cell carcinoma (HNSCC)?
Show more Head & Neck II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire